Search Results for “EC” – Page 507 – media

Surgeons Turn to Mobile App for Help with Opioid Prescriptions

In a bid to better handle the prescription and workflow processes of a practice, the orthopedic surgeons at Affiliated Oral and Maxillofacial Surgeons of Maryland have come up with a fresh mobile medication management application which allows each doctor to write about 30 prescriptions per day for controlled substances, including opioids for pain management.
- Source: HealthcareIT News
- 800
- July 12, 2018
Market Views mHealth opioid
What You Need to Know about Hepatitis C

Hepatitis C is a chronic, potentially fatal disease affecting the liver and is caused by a viral infection most frequently transmitted through large or repeated direct percutaneous exposures to infected blood. The two most common exposures associated with transmission of HCV are blood transfusion and injection drug use. It proves to be deadly because it develops silently i.e. it does not produce any marked signs and symptoms until it has progressed to an advanced stage.
- Source: Help4Hep
- 701
- July 12, 2018
health hepatitis C Researches
Medtronic Releases Results from One-Year Insulin Pump Study

On Tuesday the analysis results of a yearlong comparative study of hospital admission rates between diabetes patients using insulin pumps and those taking multiple daily injections of insulin were released by Medtronic (NYSE: MDT) and UnitedHealthcare (NYSE: UNH).
- Source: Drug Delivery Business
- 724
- July 12, 2018
diabetes Medtronic Researches
NHS IT Systems Experience Downtime of About 1300 Hours in the Last Three Years

The FoI request was sent by enterprise IT firm Intercity Technology to as many as 143 NHS trusts in England. Out of these, 80 responded, of which 25 reported outages across their IT systems during the period from January 2015 to February 2018.
- Source: DigitalHealth.net
- 696
- July 12, 2018
Company Insight cybersecurity NHS
Fitbit Charge HR – Assessment of Health Conditions in Cancer Patients

A study report published in Nature's Digital Medicine partner journal shows that the wearable monitor Fitbit Charge HR could assess the health condition of cancer patients and predict their adverse events.
- Source: MobiHealthNews
- 674
- July 12, 2018
cancer Company Insight mHealth wearables
Insufficient Sleep Worsens Hepatitis C

Fatigue is a common complaint of chronic Hepatitis C sufferers. Fatigue is triggered by many factors, but insufficient sleep is considered to be the major cause and too many sleepless nights worsen the condition of Hepatitis C sufferers.
- Source: HepatitisCentral
- 675
- July 12, 2018
hepatitis Researches
Woman’s Bone Vanished into Thin Air!

A woman aged 44 years old continuous pain in her left arm and shoulder. The doctors at the Royal Infirmary of Edinburgh in Scotland were unable to figure out the causative factor. Upon taking X-rays, they were astounded to find that the bones were disappearing. The woman was diagnosed with vanishing bone disease (Gorham-Stout disease).
- Source: LiveScience
- 733
- July 12, 2018
bone rare diseases Researches
Cerner & Lumeris Collaborate for Value-Based Care Solution

Cerner and Lumeris have brought together their technologies to result in EHR agnostic. The Kansas City, Missouri-based Cerner specializes in EHRs and other IT solutions whereas the St. Louis, Missouri-based Lumeris’ technique involves value-based care.
- Source: MedCityNews
- 810
- July 11, 2018
Company Insight EHR
US Prison Inmates with Hepatitis C Devoid of Treatment

Reports reveal that as many as 144,000 inmates of state prisons in the United States who have hepatitis C are not being given any kind of treatment. Corrections departments in every state were enquired about the number of inmates with hepatitis C, the treatment they were receiving, the drugs used for their treatment and also about policies that exist which concern inmates inflicted with the virus.
- Source: Speciality Pharmacy Times
- 646
- July 11, 2018
hepatitis C Policies
Torque’s T cell ‘Backpacks’ Show Promising Results Against Solid Tumors

Gilead’s Yescarta and Novartis’ Kymriah garnered a lot of interest among T-cell therapies after producing high response rates in patients with lymphoma and leukemia. However, the same has not been true for this technology in cases of solid tumors. In this novel procedure, patients’ immune-boosting T cells are extracted and engineered to target and destroy cancer cells.
- Source: FierceBiotech
- 1,111
- July 11, 2018
cancer Researches T-cell therapies

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.